$EQ
Equillium, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · La Jolla, CA
EQ chart
What traders are saying about $EQ
Latest postsEquillium, Inc. news
- Equillium pulls in $20M milestone tranche as EQ504 enters human trials
Dealroom ·
- Form 8K Equillium Inc For: 26 October By Investing.com
Investing.com Nigeria ·
- Equillium Secures $20 Million in Milestone Private Placement Following EQ504 Trial Initiation
Kalkine Media ·
- Equillium doses first patient in EQ504 phase 1 trial By Investing.com
Investing.com Nigeria ·
- Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
Yahoo Finance ·
- Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
Yahoo Finance ·
- Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Yahoo Finance ·
- Equillium Announces Poster Presentations at the 7th International AHR Conference
Yahoo Finance ·
- Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
marketbeat.com ·
- Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
Yahoo Finance ·
- Equillium to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- EQ Inc. Reports Second Quarter 2026 Financial Results
Yahoo Finance ·
Equillium, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $41.1M | $36.1M | $15.8M |
| Net income | -$22.4M | -$8.1M | -$13.3M | -$62.4M |
| Diluted EPS | $-0.39 | $-0.23 | $-0.38 | $-1.85 |
| Total assets (year end) | $31.9M | $25.6M | $50.5M | $78.4M |
| Cash and equivalents (year end) | $30.3M | $18.1M | $23.2M | $59.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Equillium, Inc.
- Ticker
- EQ (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- La Jolla, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1746466
Frequently asked questions
What exchange is Equillium, Inc. listed on?
Equillium, Inc. trades on the Nasdaq under the ticker symbol EQ.
What industry is Equillium, Inc. in?
Equillium, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Equillium, Inc. headquartered?
Equillium, Inc.'s business address on file with the SEC is in La Jolla, CA.
When does Equillium, Inc.'s fiscal year end?
Equillium, Inc.'s fiscal year ends on December 31.
How much revenue did Equillium, Inc. report?
Equillium, Inc. reported $41.1M in revenue for calendar year 2024, according to its SEC filings.